Tu Shih-Hsin, Huang Wan-Ting, Chew Chee Ho, Chen Amanda Lin, Chen Shou-Tung, Chen Jin-Hua, Hsieh Yi-Chen, Chen Chien-Chung
Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of Surgery, Taipei Medical University Hospital, Taipei 11052, Taiwan.
Cancers (Basel). 2023 May 15;15(10):2764. doi: 10.3390/cancers15102764.
Breast cancer is a severe public health problem, and early treatment with powerful anticancer drugs is critical for success. The researchers investigated the clinical results of a novel screening tool termed Microtube Array Membrane Hollow Fiber Assay (MTAM-HFA) in breast cancer patients in this clinical investigation. In all trial participants, the MTAM-HFA was utilized to identify active medicines for the treatment of breast cancer. The MTAM-HFA was shown to be extremely useful in predicting patient response to anticancer medication therapy in this study. Furthermore, the substantial association between the MTAM-HFA screening outcome and the clinical outcome of the respective patients emphasizes the promise of this unique screening technology in discovering effective anticancer medication combinations for the treatment of breast cancer. These findings indicate that the MTAM-HFA has clinical significance and might be a valuable tool in the development of tailored therapy for cancer care. This study provides helpful information for physicians and scientists working on breast cancer therapy research. The potential benefits of employing MTAM-HFA to find accurate therapies for breast cancer patients might lead to enhanced personalized medicine approaches to cancer care, resulting in better patient outcomes. Overall, the MTAM-HFA screening approach has the potential to revolutionize customized cancer therapy, providing hope to both patients and physicians.
乳腺癌是一个严重的公共卫生问题，早期使用强效抗癌药物进行治疗对于成功治疗至关重要。在这项临床研究中，研究人员调查了一种名为微管阵列膜中空纤维分析（MTAM-HFA）的新型筛查工具在乳腺癌患者中的临床效果。在所有试验参与者中，MTAM-HFA被用于识别治疗乳腺癌的活性药物。在本研究中，MTAM-HFA被证明在预测患者对抗癌药物治疗的反应方面非常有用。此外，MTAM-HFA筛查结果与各患者临床结果之间的显著关联强调了这种独特筛查技术在发现治疗乳腺癌的有效抗癌药物组合方面的前景。这些发现表明，MTAM-HFA具有临床意义，可能是癌症治疗中制定个性化治疗方案的有价值工具。这项研究为从事乳腺癌治疗研究的医生和科学家提供了有用信息。采用MTAM-HFA为乳腺癌患者找到精确治疗方法的潜在益处可能会导致癌症治疗中个性化医疗方法的改进，从而改善患者预后。总体而言，MTAM-HFA筛查方法有可能彻底改变个性化癌症治疗，为患者和医生都带来希望。
